A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers
Clinical trial NCT06637865 · RECRUITING
Trial details
- NCT number
- NCT06637865
- Sponsor
- Immutep S.A.S.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2026-08-31
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.